Anemia in premature infant and treatment by recombinant human erythropoietin (rHuEPO): which benefit?

被引：1
|
作者：
Klosowski, S [1 ]
Djebara, A [1 ]
Bachiri, A [1 ]
Haouari, N [1 ]
Thelliez, R [1 ]
Morisot, C [1 ]
机构：
[1] Ctr Hosp Docteur Schaffner, Serv Med Neonatale, F-62307 Lens, France
来源：
ARCHIVES DE PEDIATRIE | 2001年 / 8卷 / 12期
关键词：
blood transfusion; erythropoietin; anemia; infant; premature;
D O I：
10.1016/S0929-693X(01)00665-0
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
引用
收藏
页码：1400 / 1402
页数：3
相关论文
共 50 条
  • [1] Secondary anemia after cessation of treatment with recombinant human erythropoietin (rHuEpo).
    Loo, M
    Fillet, G
    Beguin, Y
    [J]. BLOOD, 1996, 88 (10) : 568 - 568
  • [2] Erythropoietin (rHuEPO) administration to premature infants for the treatment of their anemia
    Giannakopoulou, C
    Bolonaki, I
    Stiakaki, E
    Dimitriou, H
    Galanaki, H
    Hatzidaki, E
    Kalmanti, M
    [J]. PEDIATRIC HEMATOLOGY AND ONCOLOGY, 1998, 15 (01) : 37 - 43
  • [3] Recombinant human erythropoietin (rHuEPO) in the treatment of chronic anemia in pediatric cancer and chemotherapy
    Dornbusch, P
    Urban, C
    Thalmann, E
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 1023 - 1023
  • [4] TREATMENT OF UREMIC ANEMIA WITH ETRETINATE - COMPARISON WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN (RHUEPO)
    LAMPERI, S
    CAROZZI, S
    ICARDI, A
    NASINI, MG
    TRAVERSO, GB
    [J]. CURRENT THERAPY IN NEPHROLOGY, 1989, 24 : 158 - 160
  • [5] Cessation of intensive treatment with recombinant human erythropoietin (rHuEpo) is followed by secondary anemia
    Piron, M
    Loo, M
    Gothot, A
    Tassin, F
    Fillet, G
    Beguin, Y
    [J]. EXPERIMENTAL HEMATOLOGY, 2000, 28 (07) : 55 - 55
  • [6] Prediction of response to recombinant human erythropoietin (rHuEpo) in anemia of malignancy
    Cazzola, M
    Ponchio, L
    Pedrotti, C
    Farina, G
    Cerani, P
    Lucotti, C
    Novella, A
    Rovati, A
    Bergamaschi, G
    Beguin, Y
    [J]. HAEMATOLOGICA, 1996, 81 (05) : 434 - 441
  • [7] Prevention of anemia in premature infants: place of recombinant human erythropoietin (rHuEPO) in a level III neonatal unit
    Klosowski, S
    Kongolo, G
    Morisot, C
    Thelliez, P
    Djebara, A
    Deroubaix, P
    [J]. ARCHIVES DE PEDIATRIE, 1999, 6 (05): : 592 - 594
  • [8] Recombinant human erythropoietin (rHuEPO) in the treatment of chronic anemia in pediatric cancer and chemotherapy.
    Dornbusch, P
    Urban, C
    Thalmann, E
    [J]. BLOOD, 1995, 86 (10) : 2531 - 2531
  • [9] ESTIMATION OF THE RISK OF THROMBOSIS UNDER TREATMENT OF RENAL ANEMIA WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN (RHUEPO)
    GRUTZMACHER, P
    BERGMANN, M
    TSOBANELIS, T
    VLACHOJANNIS, J
    BREDDIN, K
    SCHOEPPE, W
    [J]. KIDNEY INTERNATIONAL, 1991, 39 (06) : 1302 - 1303
  • [10] Cost-benefit analysis of prevention of neonatal anemia with recombinant human erythropoietin in premature infants
    Glorieux, J
    Tricoire, J
    Afchar, N
    Perier, AC
    Rolland, M
    Casper, C
    [J]. PEDIATRIC RESEARCH, 2004, 56 (03) : 480 - 480
12345